Locations:
Search
Second (or third) time’s a charm in reducing splenomegaly and other symptoms
Using data science to identify intrinsic patterns in cancer data
Slightly greater risk of bleeding
Fat necrosis is a benign but real concern
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A leader in national accreditation standards comments on study
Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies
Consortium aims to reduce life-threatening side effect of therapy
Predicts drug response in patient with rare, aggressive cancer
The future of VTE risk prediction in cancer
Outcomes hold promise for future RCT results
Advertisement
Advertisement